G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 127 filers reported holding G1 THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $32,522 | -16.6% | 12,135 | +137.1% | 0.00% | – |
| Q1 2022 | $39,000 | -25.0% | 5,118 | 0.0% | 0.00% | – |
| Q4 2021 | $52,000 | -24.6% | 5,118 | 0.0% | 0.00% | – |
| Q3 2021 | $69,000 | -38.4% | 5,118 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $112,000 | -8.9% | 5,118 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $123,000 | +33.7% | 5,118 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $92,000 | +178.8% | 5,118 | +80.2% | 0.00% | – |
| Q3 2020 | $33,000 | -52.2% | 2,840 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $69,000 | +475.0% | 2,840 | +158.4% | 0.00% | – |
| Q1 2020 | $12,000 | -58.6% | 1,099 | 0.0% | 0.00% | – |
| Q4 2019 | $29,000 | +16.0% | 1,099 | 0.0% | 0.00% | – |
| Q3 2019 | $25,000 | -26.5% | 1,099 | 0.0% | 0.00% | – |
| Q2 2019 | $34,000 | +88.9% | 1,099 | 0.0% | 0.00% | – |
| Q1 2019 | $18,000 | -14.3% | 1,099 | 0.0% | 0.00% | – |
| Q4 2018 | $21,000 | -12.5% | 1,099 | +134.8% | 0.00% | – |
| Q3 2018 | $24,000 | – | 468 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 120,000 | $172,800 | 0.15% |
| DENALI ADVISORS LLC | 148,800 | $214,272 | 0.08% |
| XTX Topco Ltd | 296,601 | $427,105 | 0.07% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 234,000 | $336,960 | 0.06% |
| LEVEL FOUR ADVISORY SERVICES, LLC | 183,400 | $264,096 | 0.02% |
| Curi Wealth Management, LLC | 70,742 | $101,869 | 0.02% |
| FRANKLIN STREET ADVISORS INC /NC | 83,400 | $120 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 140,000 | $201,600 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 573,256 | $825,489 | 0.01% |
| ALGERT GLOBAL LLC | 68,100 | $98 | 0.01% |